The global nanopesticides market size is calculated at USD 783.9 billion in 2025 and is forecasted to reach around USD 2,251.9 billion by 2034, accelerating at a CAGR of 12.44% from 2025 to 2034. The Asia Pacific market size surpassed USD 244.01 billion in 2024 and is expanding at a CAGR of 12.60% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Nanopesticides Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Nanopesticides Market, by Utility
8.1.1. Food Crop
8.1.1.1. Market Revenue and Forecast
8.1.2. Industrial Crop
8.1.2.1. Market Revenue and Forecast
9.1. Nanopesticides Market, by Type
9.1.1. Nanoinsecticides
9.1.1.1. Market Revenue and Forecast
9.1.2. Nanoherbicides
9.1.2.1. Market Revenue and Forecast
9.1.3. Nanofungicides
9.1.3.1. Market Revenue and Forecast
9.1.4. Others
9.1.4.1. Market Revenue and Forecast
10.1. Nanopesticides Market, by End-user
10.1.1. Agriculture
10.1.1.1. Market Revenue and Forecast
10.1.2. Non-agriculture
10.1.2.1. Market Revenue and Forecast
11.1. Nanopesticides Market, by Target Organism
11.1.1. Algicides
11.1.1.1. Market Revenue and Forecast
11.1.2. Avicides
11.1.2.1. Market Revenue and Forecast
11.1.3. Bactericides
11.1.3.1. Market Revenue and Forecast
11.1.4. Fungicides
11.1.4.1. Market Revenue and Forecast
11.1.5. Herbicides
11.1.5.1. Market Revenue and Forecast
11.1.6. Insecticides
11.1.6.1. Market Revenue and Forecast
11.1.7. Others
11.1.7.1. Market Revenue and Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Utility
12.1.2. Market Revenue and Forecast, by Type
12.1.3. Market Revenue and Forecast, by End-user
12.1.4. Market Revenue and Forecast, by Target Organism
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Utility
12.1.5.2. Market Revenue and Forecast, by Type
12.1.5.3. Market Revenue and Forecast, by End-user
12.1.5.4. Market Revenue and Forecast, by Target Organism
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Utility
12.1.6.2. Market Revenue and Forecast, by Type
12.1.6.3. Market Revenue and Forecast, by End-user
12.1.6.4. Market Revenue and Forecast, by Target Organism
12.2. Europe
12.2.1. Market Revenue and Forecast, by Utility
12.2.2. Market Revenue and Forecast, by Type
12.2.3. Market Revenue and Forecast, by End-user
12.2.4. Market Revenue and Forecast, by Target Organism
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Utility
12.2.5.2. Market Revenue and Forecast, by Type
12.2.5.3. Market Revenue and Forecast, by End-user
12.2.5.4. Market Revenue and Forecast, by Target Organism
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Utility
12.2.6.2. Market Revenue and Forecast, by Type
12.2.6.3. Market Revenue and Forecast, by End-user
12.2.6.4. Market Revenue and Forecast, by Target Organism
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Utility
12.2.7.2. Market Revenue and Forecast, by Type
12.2.7.3. Market Revenue and Forecast, by End-user
12.2.7.4. Market Revenue and Forecast, by Target Organism
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Utility
12.2.8.2. Market Revenue and Forecast, by Type
12.2.8.3. Market Revenue and Forecast, by End-user
12.2.8.4. Market Revenue and Forecast, by Target Organism
12.3. APAC
12.3.1. Market Revenue and Forecast, by Utility
12.3.2. Market Revenue and Forecast, by Type
12.3.3. Market Revenue and Forecast, by End-user
12.3.4. Market Revenue and Forecast, by Target Organism
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Utility
12.3.5.2. Market Revenue and Forecast, by Type
12.3.5.3. Market Revenue and Forecast, by End-user
12.3.5.4. Market Revenue and Forecast, by Target Organism
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Utility
12.3.6.2. Market Revenue and Forecast, by Type
12.3.6.3. Market Revenue and Forecast, by End-user
12.3.6.4. Market Revenue and Forecast, by Target Organism
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Utility
12.3.7.2. Market Revenue and Forecast, by Type
12.3.7.3. Market Revenue and Forecast, by End-user
12.3.7.4. Market Revenue and Forecast, by Target Organism
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Utility
12.3.8.2. Market Revenue and Forecast, by Type
12.3.8.3. Market Revenue and Forecast, by End-user
12.3.8.4. Market Revenue and Forecast, by Target Organism
12.4. MEA
12.4.1. Market Revenue and Forecast, by Utility
12.4.2. Market Revenue and Forecast, by Type
12.4.3. Market Revenue and Forecast, by End-user
12.4.4. Market Revenue and Forecast, by Target Organism
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Utility
12.4.5.2. Market Revenue and Forecast, by Type
12.4.5.3. Market Revenue and Forecast, by End-user
12.4.5.4. Market Revenue and Forecast, by Target Organism
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Utility
12.4.6.2. Market Revenue and Forecast, by Type
12.4.6.3. Market Revenue and Forecast, by End-user
12.4.6.4. Market Revenue and Forecast, by Target Organism
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Utility
12.4.7.2. Market Revenue and Forecast, by Type
12.4.7.3. Market Revenue and Forecast, by End-user
12.4.7.4. Market Revenue and Forecast, by Target Organism
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Utility
12.4.8.2. Market Revenue and Forecast, by Type
12.4.8.3. Market Revenue and Forecast, by End-user
12.4.8.4. Market Revenue and Forecast, by Target Organism
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Utility
12.5.2. Market Revenue and Forecast, by Type
12.5.3. Market Revenue and Forecast, by End-user
12.5.4. Market Revenue and Forecast, by Target Organism
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Utility
12.5.5.2. Market Revenue and Forecast, by Type
12.5.5.3. Market Revenue and Forecast, by End-user
12.5.5.4. Market Revenue and Forecast, by Target Organism
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Utility
12.5.6.2. Market Revenue and Forecast, by Type
12.5.6.3. Market Revenue and Forecast, by End-user
12.5.6.4. Market Revenue and Forecast, by Target Organism
13.1. Marrone Bio Innovations
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Bioworks
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Valent Biosciences
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Andermatt Biocontrol
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Stockton
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Bayer
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Camson Bio Technologies
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Corteva
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client